Who Classification of Tumours Editorial Board (2020) Glomus tumour. Who classification of tumours: soft tissue and bone tumours. Iarc, Lyon, pp 179–181

Google Scholar 

Mohammadi O, Suarez M (2023) Glomus cancer. Statpearls. Statpearls Publishing, Treasure Island, p 32491428

Google Scholar 

Asa Sl, Kovacs K, Horvath E, Ezrin C, Weiss Mh (1984) Sellar glomangioma. Ultrastruct Pathol 7(1):49–54

Article  CAS  PubMed  Google Scholar 

Hänggi D, Adams H, Hans Vh, Probst A, Tolnay M (2005) Recurrent glomus tumor of the sellar region with malignant progression. Acta Neuropathol 110(1):93–96

Article  PubMed  Google Scholar 

Ebinu JO, Shahideh M, Ibrahim GM et al (2011) Sellar glomangioma. Endocr Pathol 22(4):218–221

Article  PubMed  Google Scholar 

Tsang J, Ng Cs, Fung Cf, Chan J, Cheuk W (2020) Glomus tumor of sella turcica with synaptophysin expression mimicking pituitary adenoma. Int J Surg Pathol 28(4):401–405

Article  PubMed  Google Scholar 

Quah Bl, Donofrio Ca, La Rosa S et al (2021) Primary glomus tumour of the pituitary gland: diagnostic challenges of a rare and potentially aggressive neoplasm. Virchows Arch 478(5):977–984

Article  CAS  PubMed  Google Scholar 

Gombos Z, Glomus PJ (2008) Glomus tumor. Arch Pathol Lab Med 132(9):1448–1452

Article  PubMed  Google Scholar 

Morey Vm, Garg B, Kotwal Pp (2016) Glomus tumours of the hand: review of literature. J Clin Orthop Trauma 7(4):286–291

Article  PubMed  PubMed Central  Google Scholar 

Jiang L, Shi J, Liu W, Kang J, Wang N (2014) Clinical feature of chronic compressive optic neuropathy without optic atrophy. Zhonghua Yan Ke Za Zhi 50(12):889–893

PubMed  Google Scholar 

Miettinen M, Paal E, Lasota J et al (2002) Gastrointestinal glomus tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 32 cases. Am J Surg Pathol 26:301–311

Article  PubMed  Google Scholar 

Møller MW, Andersen MS, Glintborg D et al (2019) Pituitary adenoma. Ugeskr Laeger 181(20):V05180331

PubMed  Google Scholar 

Asa Sl, Mete O, Perry A, Osamura Ry (2022) Overview of the 2022 WHO classification of pituitary tumors. Endocr Pathol 33(1):6–26

Article  CAS  PubMed  Google Scholar 

Kleinschmidt-Demasters Bk (2016) Histological features of pituitary adenomas and sellar region masses. Curr Opin Endocrinol Diabetes Obes 23(6):476–484

Article  PubMed  Google Scholar 

Asa Sl, Mete O (2018) Immunohistochemical biomarkers in pituitary pathology. Endocr Pathol 29(2):130–136

Article  CAS  PubMed  Google Scholar 

Spada A, Mantovani G, Lania Ag et al (2022) Pituitary tumors: genetic and molecular factors underlying pathogenesis and clinical behavior. Neuroendocrinology 112:15–33

Article  CAS  PubMed  Google Scholar 

Yang X, Jiang Q, Yu B (2015) Solitary fibrous tumor located in the sella turcica: a report of two cases and review of the literature. Oncol Lett 10:354–358

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hyrcza Md, Winer Da, Shago M et al (2017) Tfe3-expressing perivascular epithelioid cell neoplasm (Pecoma) of the sella turcica. Endocr Pathol 28:22–26

Article  CAS  PubMed  Google Scholar 

Bleeker Js, Quevedo Jf, Folpe Al (2012) “Malignant” perivascular epithelioid cell neoplasm: risk stratification and treatment strategies. Sarcoma 2012:541626

Article  PubMed  PubMed Central  Google Scholar 

Akumalla S, Madison R, Lin Di et al (2020) Characterization of clinical cases of malignant pecoma via comprehensive genomic profiling of DNA and RNA. Oncology 98:905–912

Article  CAS  PubMed  Google Scholar 

Lotsch C, Warta R, Herold-Mende C (2024) The molecular and immunological landscape of meningiomas. Int J Mol Sci 25:9631

Article  CAS  PubMed  PubMed Central  Google Scholar 

Agaimy A, Buslei R, Coras R et al (2014) Comparative study of soft tissue perineurioma and meningioma using a five-marker immunohistochemical panel. Histopathology 65:60–70

Article  PubMed  Google Scholar 

Yoshimoto K, Hatae R, Suzuki So et al (2018) High-resolution melting and immunohistochemical analysis efficiently detects mutually exclusive genetic alterations of adamantinomatous and papillary craniopharyngiomas. Neuropathology 38:3–10

Article  CAS  PubMed  Google Scholar 

Schweizer L, Koelsche C, Sahm F et al (2013) Meningeal hemangiopericytoma and solitary fibrous tumors carry the Nab2-Stat6 fusion and can be diagnosed by nuclear expression of stat6 protein. Acta Neuropathol 125:651–658

Article  CAS  PubMed  Google Scholar 

Shen J, Shrestha S, Yen Yh et al (2015) Pericyte antigens in perivascular soft tissue tumors. Int J Surg Pathol 23(8):638–648

Article  CAS  PubMed  PubMed Central  Google Scholar 

Folpe Al, Fanburg-Smith Jc, Miettinen M, Weiss Sw (2001) Atypical and malignant glomus tumors: analysis of 52 cases, with a proposal for the reclassification of glomus tumors. Am J Surg Pathol 25(1):1–12

Article  CAS  PubMed  Google Scholar 

Chen Jh, Lin L, Liu Kl et al (2020) Malignant glomus tumor of the intestinal ileum with multiorgan metastases: a case report and review of literature. World J Gastroenterol 26(7):770–776

Article  PubMed  PubMed Central  Google Scholar 

Hegyi L, Cormack Gc, Grant Jw (1998) Histochemical investigation into the molecular mechanisms of malignant transformation in a benign glomus tumour. J Clin Pathol 51(11):872–874

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karamzadeh Dashti N, Bahrami A, Lee Sj et al (2017) Braf V600e mutations occur in a subset of glomus tumors, and are associated with malignant histologic characteristics. Am J Surg Pathol 41(11):1532–1541

Article  PubMed  Google Scholar 

Hy X, Rq S, Jx Z et al (2023) Association of Braf variants with disease characteristics, prognosis, and targeted therapy response in intrahepatic cholangiocarcinoma. Jama Netw Open 6(3):E231476

Article  Google Scholar 

Dribnokhodova Op, Esman As, Korchagin Vi et al (2022) A complex of pyrosequencing-based methods for detection of somatic mutations in codons 600 and 601 of the BRAF gene. Sovrem Technol Med 14(2):41–49

Article  CAS  Google Scholar 

Davies H, Bignell Gr, Cox C et al (2002) Mutations of the BRAF gene in human cancer. Nature 417(6892):949–954

Article  CAS  PubMed  Google Scholar 

Afkhami M, Karunamurthy A, Chiosea S et al (2016) Histopathologic and clinical characterization of thyroid tumors carrying the Braf(K601e) mutation. Thyroid 26:242–247

Article  CAS  PubMed  Google Scholar 

Moiseyenko Fv, Egorenkov Vv, Kramchaninov Mm et al (2019) Lack of response to Vemurafenib in melanoma carrying Braf K601e mutation. Case Rep Oncol 12(2):339–343

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kinno T, Tsuta K, Shiraishi K et al (2014) Clinicopathological features of nonsmall cell lung carcinomas with Braf mutations. Ann Oncol 25(1):138–142